US Stock MarketDetailed Quotes

ANIP ANI Pharmaceuticals

Watchlist
  • 54.160
  • -0.050-0.09%
Close Dec 24 13:00 ET
  • 52.550
  • -1.610-2.97%
Pre 05:38 ET
1.14BMarket Cap-115.23P/E (TTM)

ANI Pharmaceuticals Key Stats

ANI Pharmaceuticals Q3 2024 Earnings Date

Currency:USDNov 8, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
144.37M
148.33M
+3.96M
Beat Est.
+9.52%
+12.52%
+2.74%
EPS
-<0.01
-1.27
-1.27
Miss Est.
-100.71%
-382.22%
-39587.50%
Strong Buy

Dec 18, 2024

ANI Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 165.344M--
--2024/Q4-- / 175.082M--
Nov 8, 20242024/Q3148.332M / 144.375M--
Aug 6, 20242024/Q2138.040M / 129.053M--
May 10, 20242024/Q1137.430M / 126.028M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 165.344M--
--2024/Q4-- / 175.082M--
Nov 8, 20242024/Q3148.332M / 144.375M--
Aug 6, 20242024/Q2138.040M / 129.053M--
May 10, 20242024/Q1137.430M / 126.028M--

Unlock Free Earnings Estimates

ANI Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 18, 2024

Strong Buy

  • Buy

    75.00%
  • Hold

    25.00%
  • Sell

    0.00%

Price Target

No Data